Combivent and Daptomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivent (albuterol sulfate; ipratropium bromide) and Daptomycin (daptomycin). Common drug interactions include acute respiratory distress syndrome among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Combivent and Daptomycin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.



On Aug, 05, 2026

16 people who take Combivent and Daptomycin together, and have interactions are studied.

Combivent and Daptomycin drug interactions.

What are the common drug interactions of Combivent and Daptomycin, by gender? *:

female:

  1. Acute respiratory distress syndrome
  2. Ammonia increased
  3. Cardiac arrest
  4. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  5. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  6. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Septic shock (shock due to blood infection)
  9. Skin disorder (skin disease)
  10. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

male:

  1. Arrhythmia (irregular heartbeat)
  2. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Pneumonia

What are the common drug interactions of Combivent and Daptomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Acute respiratory distress syndrome
  2. Ammonia increased
  3. Cardiac arrest
  4. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  5. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  6. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Septic shock (shock due to blood infection)
  9. Skin disorder (skin disease)
  10. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

40-49:

  1. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Cellulitis (infection under the skin)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Heparin-induced thrombocytopenia
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)

50-59:

  1. Arrhythmia (irregular heartbeat)
  2. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Pneumonia

60+:

  1. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 2 people, 12.50%
  2. Adverse Event: 2 people, 12.50%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 6.25%
  4. Pain: 1 person, 6.25%
  5. Nausea (feeling of having an urge to vomit): 1 person, 6.25%
  6. Fever: 1 person, 6.25%
  7. Device Related Infection: 1 person, 6.25%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.25%
  9. Agitation (state of anxiety or nervous excitement): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and Daptomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Combivent and Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide and daptomycin (the active ingredients of Combivent and Daptomycin, respectively), and Combivent and Daptomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: